Compassionate Use of Nirogacestat for Individual Patients

Sponsor: SpringWorks Therapeutics, Inc.

Expanded Access
Sponsor score: 60

ClinicalTrials ID:NCT05041036

Provider View

This program allows individual patients to access the drug Nirogacestat on a case-by-case basis, with necessary approvals from the company, ethics boards, and relevant authorities.

Patient Parameters

Program Overview

The compassionate use program for Nirogacestat is designed to provide access to this medication for patients who have serious or life-threatening conditions and have no other satisfactory treatment options available. Each request for the drug is considered individually and requires approval from the drug company, ethics committees, and relevant health authorities.

Eligibility Criteria

Inclusion Criteria

  • The patient has a serious, debilitating, or life-threatening condition that cannot be effectively treated with existing approved medications or other standard treatments.
  • The patient is not eligible to participate in any ongoing clinical trials.

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.